- Home
- CJMB vs HCWB Comparison
CJMB vs HCWB Comparison
Compare CJMB & HCWB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CJMB
- HCWB
- Stock Information
- Founded
- CJMB 2007
- HCWB 2018
- Country
- CJMB United States
- HCWB United States
- Employees
- CJMB N/A
- HCWB N/A
- Industry
- CJMB
- HCWB Biotechnology: Pharmaceutical Preparations
- Sector
- CJMB
- HCWB Health Care
- Exchange
- CJMB NYSE
- HCWB Nasdaq
- Market Cap
- CJMB 18.8M
- HCWB 17.2M
- IPO Year
- CJMB 2025
- HCWB 2021
- Fundamental
- Price
- CJMB $5.54
- HCWB $0.39
- Analyst Decision
- CJMB
- HCWB
- Analyst Count
- CJMB 0
- HCWB 0
- Target Price
- CJMB N/A
- HCWB N/A
- AVG Volume (30 Days)
- CJMB 891.7K
- HCWB 18.3M
- Earning Date
- CJMB 01-01-0001
- HCWB 03-31-2025
- Dividend Yield
- CJMB N/A
- HCWB N/A
- EPS Growth
- CJMB N/A
- HCWB N/A
- EPS
- CJMB N/A
- HCWB N/A
- Revenue
- CJMB $6,884,783.00
- HCWB $3,495,990.00
- Revenue This Year
- CJMB N/A
- HCWB $229.19
- Revenue Next Year
- CJMB N/A
- HCWB N/A
- P/E Ratio
- CJMB N/A
- HCWB N/A
- Revenue Growth
- CJMB N/A
- HCWB 22.27
- 52 Week Low
- CJMB $3.38
- HCWB $0.21
- 52 Week High
- CJMB $7.76
- HCWB $2.52
- Technical
- Relative Strength Index (RSI)
- CJMB N/A
- HCWB 48.72
- Support Level
- CJMB N/A
- HCWB $0.38
- Resistance Level
- CJMB N/A
- HCWB $0.42
- Average True Range (ATR)
- CJMB 0.00
- HCWB 0.09
- MACD
- CJMB 0.00
- HCWB -0.00
- Stochastic Oscillator
- CJMB 0.00
- HCWB 4.48
About HCWB HCW Biologics Inc.
HCW Biologics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing novel immunotherapies to lengthen the health span by disrupting the link between chronic, low-grade inflammation and age-related diseases. The company has developed TOBI discovery platform, or Tissue factor-based fusion discovery platform, for the design of category-defining immunotherapeutic drugs. It has selected two molecules as its product candidate; HCW9218 and HCW9302. HCW9218 is a bifunctional immunotherapeutic designed with the capabilities to neutralize transforming growth and stimulate immune cells. HCW9302 is designed to activate and expand regulatory T cells, which deactivate inflammasomes.